About Fakultna Nemocnica Nitra
The Faculty Hospital in Nitra is a hospital in the city of Nitra, in western Slovakia. Its address is Špitalská 6, 950 01, Nitra. It is attached to the Constantine the Philosopher University in Nitra.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Arena Pharmaceuticals
2
Baxalta now part of Shire
2
Celgene
2
Pfizer
2
Advanz Pharma
1
Bayer
1
Ferring Pharmaceuticals
1
Galapagos NV
1
Hoffmann-La Roche
1
Janssen Research & Development, LLC
1
Janssen Scientific Affairs, LLC
1
Clinical Trials at Fakultna Nemocnica Nitra
During the past decade, Fakultna Nemocnica Nitra conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
2006-03-01
2008-12-01
Terminated
311
Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
2007-03-01
2008-07-01
Completed
735
Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis
2013-04-01
2014-04-01
Completed
45
A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors
2014-08-12
2020-04-06
Completed
359
A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
2015-12-15
2022-02-23
Completed
138
Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
2015-12-08
2018-01-05
Terminated
701
A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease
2016-07-25
2018-01-04
Terminated
310
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Fakultna Nemocnica Nitra" #1 sponsor was "Arena Pharmaceuticals" with 2 trials, followed by "Baxalta now part of Shire" with 2 trials
sponsored, "Celgene" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Advanz Pharma"
with 2 trials sponsored. Other sponsors include 5 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Fakultna Nemocnica Nitra"
#1 collaborator was "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Fakultna Nemocnica Nitra
According to Clinical.Site data, the most researched conditions in "Fakultna Nemocnica Nitra" are
"Ulcerative Colitis" (4 trials), "Chronic Inflammatory Demyelinating Polyradiculoneuropathy" (2 trials), "Crohn's Disease" (2 trials), "Multiple Sclerosis" (2 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Fakultna Nemocnica Nitra" in a lesser frequency.
Clinical Trials Intervention Types at Fakultna Nemocnica Nitra
Most popular intervention types in "Fakultna Nemocnica Nitra" are "Drug" (15 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Etrasimod" (3 trials), "GED-0301" (2 trials), "HYQVIA" (2 trials) and "Mavenclad®" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Fakultna Nemocnica Nitra
The vast majority of trials in "Fakultna Nemocnica Nitra" are
18 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Fakultna Nemocnica Nitra
Currently, there are NaN active trials in "Fakultna Nemocnica Nitra".
undefined are not yet recruiting,
2 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Fakultna Nemocnica Nitra,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Fakultna Nemocnica Nitra, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".